For research use only. Not for therapeutic Use.
RNF5 inhibitor inh-02 is a potent inhibitor of E3 ubiquitin ligase RNF5/RMA1. RNF5 inhibitor inh-02 leads to significant F508del-CFTR rescue (EC50=2.2 uM) in bronchial epithelial cells homozygous for the F508del mutation. RNF5 inhibitor inh-02 can be used for cystic fibrosis research[1].
Catalog Number | I035641 |
CAS Number | 324579-65-9 |
Synonyms | N-(4-benzyl-3-methyl-1,2,4-thiadiazol-5-ylidene)-N’-phenylbenzenecarboximidamide |
Molecular Formula | C23H20N4S |
Purity | ≥95% |
InChI | InChI=1S/C23H20N4S/c1-18-26-28-23(27(18)17-19-11-5-2-6-12-19)25-22(20-13-7-3-8-14-20)24-21-15-9-4-10-16-21/h2-16H,17H2,1H3 |
InChIKey | FYZFQLYZABRFAZ-UHFFFAOYSA-N |
SMILES | CC1=NSC(=NC(=NC2=CC=CC=C2)C3=CC=CC=C3)N1CC4=CC=CC=C4 |
Reference | [1]. Elvira Sondo, et al. Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia. Cell Chem Biol. 2018 Jul 19;25(7):891-905.e8. |